Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats
•Like buprenorphine alone, buprenorphine/naloxone does not depress ventilation in rats.•IV buprenorphine/naloxone injection induces withdrawal symptoms in tolerant rats.•Naloxone does not prevent the deleterious respiratory effects of buprenorphine/diazepam. Respiratory depression has been attribute...
Gespeichert in:
Veröffentlicht in: | Toxicology letters 2014-07, Vol.228 (2), p.75-84 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Like buprenorphine alone, buprenorphine/naloxone does not depress ventilation in rats.•IV buprenorphine/naloxone injection induces withdrawal symptoms in tolerant rats.•Naloxone does not prevent the deleterious respiratory effects of buprenorphine/diazepam.
Respiratory depression has been attributed to buprenorphine (BUP) misuse or combination with benzodiazepines. BUP/naloxone (NLX) has been marketed as maintenance treatment, aiming at preventing opiate addicts from self-injecting crushed pills. However, to date, BUP/NLX benefits in comparison to BUP alone remain debated. We investigated the plethysmography effects of BUP/NLX in comparison to BUP/solvent administered by intravenous route in naive and BUP-tolerant Sprague-Dawley rats, and in combination with diazepam (DZP) or its solvent. In naive rats, BUP/NLX in comparison to BUP significantly increased respiratory frequency (f, P |
---|---|
ISSN: | 0378-4274 1879-3169 |
DOI: | 10.1016/j.toxlet.2014.04.009 |